Announcement
·
29 Jan 2025
·
M42 signals genomics expansion with strategic partnership with Uzbekistan’s Ministry of Health on the Uzbek Genome Program
Learn More

Arab Health 2025

AH2025 Linkedin Event Banner Min

The Future of Health Starts Here – Join M42 at Arab Health 2025

M42 is proud to take center stage at Arab Health 2025, showcasing the innovations shaping the next era of healthcare. Over four dynamic days, we’ll dive into the transformative power of the four Ps: Precision, Prevention, Prediction and Partnership. Discover how we’re shifting the focus from sickness to prevention by harnessing the power of genomics and AI and advancing innovation in health across our diverse network.Join us in Dubai as we inspire action, spark collaboration and redefine what’s possible for the health of people and the planet.

Be part of the change.

Event Type
Exhibitions
Date & Time:
27-30 January 2025
Venue:
Dubai World Trade Centre
Get Direction

M42 Schedule

    Speakers

    • Hasan Jasem Al Nowais
      Managing Director & Group Chief Executive Officer, M42

      Hasan Jasem Al Nowais is the CEO of M42, a global tech-enabled healthcare company based in Abu Dhabi, UAE, bringing extensive leadership experience in both healthcare and hospitality sectors.

    • James R. Mault, MD, FACS
      Founder & Chief Executive Officer, BioIntelliSense

      James Mault, MD, is the Founder and CEO of BioIntelliSense, pioneering a platform that delivers medical-grade biosensors for scalable patient monitoring and clinical intelligence.

    • Dimitris Moulavasilis
      Interim Group Chief Operating Officer, M42

      Dimitris Moulavasilis is the Interim COO at M42, bringing 30+ years of experience in healthcare tech, having previously led digital innovations at Diaverum and AI initiatives at Affidea.

    • Kareem Shahin
      Chief Executive Officer, Malaffi

      Kareem Shahin, CEO of ADHDS, brings 20+ years of healthcare leadership, having previously served at G42, PwC, and IBM, where he drove growth and fostered key regional partnerships.

    • James Edward Sibley
      Group Chief Financial Officer for M42

      James Edward Sibley is the CFO of M42, overseeing financial operations and growth, and previously played a pivotal role in shaping growth strategies at Mubadala Health while holding key positions in Mergers and Acquisitions.

    • Tiago Magalhães
      Vice President Bioinformatics, M42

      Tiago Magalhães, VP of Bioinformatics at M42, leads large-scale genomics projects and has previously served as VP at Genomics Medicine Ireland, in addition to founding a personalized medicine start-up.

    • Paul Jones
      Chief Executive Officer, Omics Centre of Excellence

      Paul Jones, CEO of M42’s Omics Centre of Excellence, drives advancements in genomics and precision medicine with 30+ years of experience in global genomic programs and personalized health solutions.

    • Dr. Ahmad Al Awadhi, PhD
      Director of Community Outreach, G42

      Dr. Ahmad Al Awadhi leads community outreach at G42, focusing on public education and spearheading recruitment for the Emirati Genome Programme.

    • Dr. Alia AlMansoori, MD
      Consultant Plastic & Reconstructive Surgeon, Healthpoint

      Dr. Alia AlMansoori specializes in breast reconstruction and microsurgery for lymphedema, pioneering innovative surgical techniques to enhance patient outcomes and quality of life.

    • Dr. Stephen R. Grobmyer, MD
      Institute Chair, Oncology Institute, Cleveland Clinic Abu Dhabi

      Dr. Stephen R. Grobmyer chairs the Oncology Institute at Cleveland Clinic Abu Dhabi, where his groundbreaking research focuses on developing innovative treatments for breast cancer prevention and care.

    • Dr. Richard Marshall CBE
      CEO, Juvenescence

      Dr. Richard Marshall, a physician-scientist with 20 years of leadership in Pharmaceutical R&D, is passionate about developing new medicines and advancing Juvenescence's mission to enhance global healthspan.

    • Jim Mellon
      Co-founder/ Deputy Chairman Juvenescence

      Jim Mellon, co-founder and Deputy Chairman of Juvenescence, was inspired by advancements in longevity. His global conversations with leading scientists sparked the vision to reinvent human aging.

      • Explore Cutting-Edge Insights from Arab Health 2024

        Learn More